http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112716966-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2021-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112716966-B |
| titleOfInvention | Empagliflozin pharmaceutical composition and preparation method thereof |
| abstract | The invention discloses an engletin pharmaceutical composition and a preparation method thereof, wherein the composition comprises engletin, saxagliptin and pharmaceutically acceptable auxiliary materials; the parts by weight of the engelizin and the saxagliptin are as follows: the mass ratio of the saxagliptin to the engagliflozin is (1-2) to (2-1); the pharmaceutically acceptable auxiliary materials comprise: filler, disintegrant, adhesive, glidant, lubricant and framework material. The preparation method comprises the steps of carrying out wet granulation on all saxagliptin, half amount of the engeletin, part of the disintegrant and the framework material, and then adding the rest of the engeletin and the disintegrant for tabletting to obtain the compound tablet. Has the characteristics of quick release, lasting drug effect, stable sugar control and small side effect. |
| priorityDate | 2021-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 193.